Literature DB >> 20668307

Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB.

Leonard Amaral1, Ana Martins, Joseph Molnar, Jette E Kristiansen, Marta Martins, Miguel Viveiros, Liliana Rodrigues, Gabriella Spengler, Isabel Couto, Jorge Ramos, Sujata Dastidar, Séamus Fanning, Matt McCusker, Jean-Marie Pages.   

Abstract

Phenothiazines have their primary effects on the plasma membrane of prokaryotes and eukaryotes. Among the components of the prokaryotic plasma membrane affected are efflux pumps, their energy sources, energy providing enzymes such as ATPases, and genes that regulate and code for permeability aspects of the bacterium. The responses of multi-drug (MDR) and extensively drug resistant (XDR) Mycobacterium tuberculosis to the neuroleptic phenothiazine thioridazine are reviewed. The information collated suggests that this phenothiazine has the potential to cure XDR and MDR tuberculosis infections, a potential that has been recently demonstrated by its ability to cure 10 patients who presented with XDR TB infections. The mechanism by which this phenothiazine produces the desired effects within the infected macrophage is also discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668307

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

1.  Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria.

Authors:  Vitória S Foletto; Taciéli F da Rosa; Marissa B Serafin; Angelita Bottega; Laísa N Franco; Bruno R de Paula; Rosmari Hörner
Journal:  World J Microbiol Biotechnol       Date:  2021-02-19       Impact factor: 3.312

Review 2.  Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.

Authors:  A C Sweetland; A Kritski; M A Oquendo; M E Sublette; A Norcini Pala; L R Batista Silva; A Karpati; E C Silva; M O Moraes; J R Lapa E Silva; M L Wainberg
Journal:  Int J Tuberc Lung Dis       Date:  2017-08-01       Impact factor: 2.373

3.  Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.

Authors:  L Jeyaseeli; A Dasgupta; S G Dastidar; J Molnar; L Amaral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

4.  FIGHTING MULTIPLE DRUG RESISTANCE: EFFECTS OF UV-ACTIVATED CHLORPROMAZINE ON RABBIT'S EYE PSEUDOTUMOURS.

Authors:  Ruxandra Angela Pirvulescu; Alina Popa Cherecheanu; Mihaela Oana Romanitan; Ana Maria Dascalu; Cristina Alexandrescu
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

5.  Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.

Authors:  B M Yashodhara; Choo Beng Huat; Lakshmi Nagappa Naik; Shashikiran Umakanth; Manjunatha Hande; Joseph M Pappachan
Journal:  Infect Drug Resist       Date:  2010-10-22       Impact factor: 4.003

6.  Exposure of chlorpromazine to 266 nm laser beam generates new species with antibacterial properties: contributions to development of a new process for drug discovery.

Authors:  Mihail Lucian Pascu; Balazs Danko; Ana Martins; Nikoletta Jedlinszki; Tatiana Alexandru; Viorel Nastasa; Mihai Boni; Andra Militaru; Ionut Relu Andrei; Angela Staicu; Attila Hunyadi; Seamus Fanning; Leonard Amaral
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

7.  Mechanisms of resistance in bacteria: an evolutionary approach.

Authors:  Ana Martins; Attila Hunyadi; Leonard Amaral
Journal:  Open Microbiol J       Date:  2013-03-22

8.  Synthesis and antibacterial activity of a new derivative of the Meldrun acid: 2,2-dimethyl-5-(4H-1,2,4-triazol-4-ylaminomethylene)-1,3-dioxane-4,6-dione (C9H10N4O4).

Authors:  Gillena M M Sampaio; Alexandre M R Teixeira; Henrique D M Coutinho; Diniz M Sena Junior; Paulo T C Freire; Ricardo R F Bento; Luiz E Silva
Journal:  EXCLI J       Date:  2014-09-01       Impact factor: 4.068

9.  Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them.

Authors:  Leonard Amaral; Ana Martins; Gabriella Spengler; Joseph Molnar
Journal:  Front Pharmacol       Date:  2014-01-03       Impact factor: 5.810

10.  Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient.

Authors:  Leonard Amaral; Joseph Molnar
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.